Abbott Laboratories announces $5 billion buyback plan

Health care products company Abbott Laboratories will buy up to $5 billion in stock under a newly announced share buyback program.

According to a Securities and Exchange commission filing, North Chicago-based Abbott had just over 1.54 billion shares of common stock outstanding as of June 30. The buyback program has no time limit.

Shares of Abbott closed at $49.45 Friday.